ArticleDiabetology & metabolic syndrome2014

Efficacy and safety of vildagliptin, Saxagliptin or Sitagliptin as add-on therapy in Chinese patients with type 2 diabetes inadequately controlled with dual combination of traditional oral hypoglycemic agents.

Chun-Jun Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.